prolidase deficiency pd extremely uncommon autosomal recessive disorder associated collagen affects connective tissues thus diverse array organ systems broadly though extremely inconsistent expression collagen structural protein found ia bone skin connective tissues broken iminodipeptides end lifecycle dipeptides containing cterminal proline hydroxyproline would normally broken enzyme prolidase recovering thus recycling constituent amino acids due genetic defect prolidase activity individuals pd either knocked severely reduced affected therefore eliminate excessive amounts iminodipeptides wasting precious resource debilitating effects prolidase deficiency generally becomes evident infancy initial symptoms first manifest anytime birth young adulthood condition results diverse set severity vary significantly patients depending degree prolidase activity hampered individual underlying mutations case even possible though rare affected individuals asymptomatic case disorder identified laboratory screening prospective patient andor extended familycitation needed one signature features pd elimination high quantities peptides urinecitation needed addition affected exhibit persistent skin lesions starting mild rash ulcers primarily legs feet formation normally begins clinically among dermatological issues represent distinguishing frequent may never recede potentially leading severe infections worst case necessitate amputation pd patients exhibit weak immune system markedly elevated vulnerability infections general particularly respiratory system leading suffer pd acquire recurrent lung disease may also enlarged spleen splenomegaly occasions spleen liver may enlarged photosensitivity hyperkeratosis associated pd abnormal facial characteristics consisting pronounced eyes spaced far apart hypertelorism high forehead compressed bridge nose saddle nose small lower jaw chin micrognathia also observed majority affected pd also suffer intellectual disabilities approx recorded cases ranging mild severe mental development childhood may therefore progress slowly prolidase deficiency result mutations pepd gene located chromosome coding prolidase enzyme also known least different mutations pepd gene identified individuals affected prolidase involved degradation certain iminodipeptides containing cterminal proline hydroxyproline formed breakdown collagen recycling constituent amino acids proline hydroxyproline making available cell reuse least synthesis new collagen recycling prolidase seen image essential maintaining prolinebased systems cell collagenrich extracellular matrix ecm serves physically support structure internal organs connective tissues inadequate recycling due dysfunctional prolidase enzyme caused appropriate mutation pertinent gene leads deterioration support structure therefore connective tissue skin capillaries lymphatic tissue case pdcitation needed particular proposed buildup nondegraded dipeptides might induce programmed celldeath apoptosis whereafter cells contents would expelled neighbouring tissue potentially resulting inflammation giving rise dermatological problems seen pd similarly dysfunctional collagen metabolism likely interfere physiological remodelling processes extracellular matrix require collagen dynamically degraded rebuilt might cause problems skin wellcitation needed mental impairment observed pd might reasonably arise complications involving neuropeptides proteins abundance proline involved communication brain condition inherited autosomal recessive fashion meaning copies gene contained every cell alleles mutated parents person suffers autosomal recessive disorder possesses one copy mutant gene usually exhibit signs symptoms disorder copy functional compensate deleterious pd diagnosis based primarily presence position ulcers skin well identifying particular protein markers urine confirm diagnosis blood test required measure prolidase activitycitation needed curative treatment available prolidase deficiency time although palliative treatment possible extent latter mainly focuses treating skin lesions standard methods stalling collagen degradation boosting prolidase performance possible keep intracellular dipeptide levels low give cells time resynthesise absorb proline recycle able rebuild collagen degrade patients treated orally ascorbate aka vitamin c cofactor prolyl hydroxylase enzyme hydroxylates proline increasing collagen stability manganese cofactor prolidase suppression collagenase collagen degrading enzyme local applications ointments contain lglycine lproline response treatment inconsistent affected therapeutic approach based enzyme replacement administering functional prolidase due weakened immune response pd cases also paramount importance keep infections control often heavy antibiotics httpsenwikipediaorgwikiprolidasedeficiency